Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and XXXX Survivors in the United States.

@entity1 @entity263 @entity0 @entity5 @entity717
BACKGROUND: There are limited nationally representative estimates of the annual economic burden among survivors of the three most prevalent @entity5 (colorectal, female breast, and prostate) in both nonelderly and elderly populations in the United States. METHODS: The 2008 to 2012 Medical Expenditure Panel Survey data were used to identify colorectal (n = 540), female breast (n = 1568), and prostate (n = 1170) @entity5 survivors and individuals without a @entity5 history (n = 109 423). Excess economic burden attributable to @entity5 included per- @entity1 excess annual medical expenditures and productivity losses (employment disability, missed work days, and days stayed in bed). All analyses were stratified by @entity5 site and age (nonelderly: 18-64 years vs elderly: >= 65 years). Multivariable analyses controlled for age, sex, race/ethnicity, marital status, education, number of comorbidities, and geographic region. All statistical tests were two-sided. RESULTS: Compared with individuals without a @entity5 history, @entity5 survivors experienced annual excess medical expenditures (for the nonelderly population, colorectal:  8647, 95% confidence interval [CI] =  4932 to  13 974, P < .001; breast:  5119, 95% CI =  3439 to  7158, P < .001; prostate:  3586, 95% CI =  1792 to  6076, P < .001; for the elderly population, colorectal:  4913, 95% CI =  2768 to  7470, P < .001; breast:  2288, 95% CI =  814 to  3995, P = .002; prostate:  3524, 95% CI =  1539 to  5909, P < .001). Nonelderly @entity0 survivors experienced statistically significant @entity717 (13.6%, P < .001, and 4.8%, P = .001) and productivity loss at work (7.2 days, P < .001, and 3.3 days, P = .002) and at home (4.5 days, P < .001, and 3.3 days, P = .003). In contrast, elderly survivors of all three @entity5 sites had comparable productivity losses as those without a @entity5 history. CONCLUSIONS: Colorectal, breast, and @entity263 survivors experienced statistically significantly higher economic burden compared with individuals without a @entity5 history; however, excess economic burden varies by @entity5 site and age. Targeted efforts will be important in reducing the economic burden of @entity0 .
